1. Home
  2. TBPH vs CTBI Comparison

TBPH vs CTBI Comparison

Compare TBPH & CTBI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Theravance Biopharma Inc.

TBPH

Theravance Biopharma Inc.

HOLD

Current Price

$18.73

Market Cap

993.7M

Sector

Health Care

ML Signal

HOLD

Logo Community Trust Bancorp Inc.

CTBI

Community Trust Bancorp Inc.

HOLD

Current Price

$57.16

Market Cap

959.5M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
TBPH
CTBI
Founded
2013
1903
Country
United States
United States
Employees
N/A
N/A
Industry
Biotechnology: Pharmaceutical Preparations
Major Banks
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
993.7M
959.5M
IPO Year
N/A
N/A

Fundamental Metrics

Financial Performance
Metric
TBPH
CTBI
Price
$18.73
$57.16
Analyst Decision
Strong Buy
Buy
Analyst Count
5
3
Target Price
$27.80
$59.00
AVG Volume (30 Days)
601.0K
48.2K
Earning Date
11-10-2025
01-14-2026
Dividend Yield
N/A
3.69%
EPS Growth
N/A
17.49
EPS
0.58
5.17
Revenue
$80,327,000.00
$261,447,000.00
Revenue This Year
$70.78
$21.01
Revenue Next Year
N/A
$6.33
P/E Ratio
$32.19
$11.12
Revenue Growth
27.12
13.97
52 Week Low
$7.90
$44.60
52 Week High
$20.33
$59.83

Technical Indicators

Market Signals
Indicator
TBPH
CTBI
Relative Strength Index (RSI) 58.73 64.65
Support Level $18.39 $54.83
Resistance Level $20.32 $56.41
Average True Range (ATR) 0.87 1.11
MACD -0.05 0.34
Stochastic Oscillator 53.71 90.10

Price Performance

Historical Comparison
TBPH
CTBI

About TBPH Theravance Biopharma Inc.

Theravance Biopharma Inc is a diversified biopharmaceutical company focused on the discovery, development, and commercialization of organ-selective medicines. Its purpose is to pioneer a new generation of small-molecule drugs designed to meet patient needs. Its research is focused on the areas of inflammation and immunology. The firm applies organ-selective expertise to target disease biologically, to discover and develop medicines that may expand the therapeutic index with the goal of maximizing efficacy and limiting systemic side effects. The company develops lung-selective medicines to treat respiratory disease, including FDA-approved YUPELRI (revefenacin) inhalation solution indicated for the maintenance treatment of patients with chronic obstructive pulmonary disease (COPD).

About CTBI Community Trust Bancorp Inc.

Community Trust Bancorp Inc is a bank holding company. The Bank owns all the capital stock of one commercial bank and one trust company, serving small and mid-sized communities in eastern, north-eastern, central, and southcentral Kentucky, southern West Virginia, and north-eastern Tennessee. Through its subsidiaries, the Bank is engaged in commercial and personal banking and trust and wealth management activities, which include accepting time and demand deposits; making secured and unsecured loans to corporations, individuals, and others; providing cash management services to corporate and individual customers; issuing letters of credit; renting safe deposit boxes; and providing funds transfer services.

Share on Social Networks: